Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 2 Unknown 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 8 Stomach Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Colorectal Neoplasms 5 Melanoma 4 Carcinoma, Renal Cell 4 Carcinoma, Transitional Cell 3 Uterine Cervical Neoplasms 2 Sarcoma 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Mesothelioma 2 Cholangiocarcinoma 2 Carcinoma, Hepatocellular 2 Advanced Solid Tumor 2 Adenocarcinoma Of Esophagus 2 Uveal Melanoma 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Testicular Germ Cell Tumor 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Patients With Initially Unresectable MSS-type Advanced Colorectal Cancer With Liver and/or Lung and Peritoneal Metastasis 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neuroendocrine Tumors 1 Neoplasms, Unknown Primary 1 Nasopharyngeal Carcinoma 1 Lung Neoplasms 1 Locally Advanced Rectal Cancer 1

Interventions

Nivolumab 10 Doxorubicin 10 Cyclophosphamide 10 Vinblastine 9 Radiotherapy 8 Dacarbazine 8 Brentuximab Vedotin 8 Bleomycin 7 fludarabine phosphate 6 fludarabine 6 Prednisone 6 Etoposide 6 pembrolizumab 5 Melphalan 5 Whole-Body Irradiation 4 Vincristine 4 Mycophenolic Acid 4 Filgrastim 4 Tacrolimus 3 Radiation 3 Prednisolone 3 Peripheral Blood Stem Cell Transplantation 3 Granulocyte Colony-Stimulating Factor 3 Busulfan 3 Thiotepa 2 Sirolimus 2 Procarbazine 2 Mechlorethamine 2 Bendamustine Hydrochloride 2 tislelizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Hodgkin Disease × tislelizumab × Clear all

NCT05502250 2026-03-06

HOVON164HL

Stichting Hemato-Oncologie voor Volwassenen Nederland

Phase 2 Active not recruiting

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡